SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-117596
Filing Date
2016-08-09
Accepted
2016-08-09 14:52:59
Documents
54
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v445492_10q.htm 10-Q 391696
2 EXHIBIT 10.3 v445492_ex10-3.htm EX-10.3 57975
3 EXHIBIT 31.1 v445492_ex31-1.htm EX-31.1 10687
4 EXHIBIT 31.2 v445492_ex31-2.htm EX-31.2 10709
5 EXHIBIT 32.1 v445492_ex32-1.htm EX-32.1 4167
6 EXHIBIT 32.2 v445492_ex32-2.htm EX-32.2 4197
  Complete submission text file 0001144204-16-117596.txt   3395087

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lbio-20160630.xml EX-101.INS 679257
8 XBRL TAXONOMY EXTENSION SCHEMA lbio-20160630.xsd EX-101.SCH 28725
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lbio-20160630_cal.xml EX-101.CAL 29593
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lbio-20160630_def.xml EX-101.DEF 233806
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lbio-20160630_lab.xml EX-101.LAB 272813
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lbio-20160630_pre.xml EX-101.PRE 265540
Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120
Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 161817450
SIC: 2836 Biological Products, (No Diagnostic Substances)